Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Keech

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
The Lancet. Diabetes & Endocrinology|December 22, 2019
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participantsNelson Wang, Jordan Fulcher, Nishan Abeysuriya, et al.
Resuscitation|April 12, 2026
Healthcare costs of expedited transport compared with standard care following out-of-hospital cardiac arrest: results from the EVIDENCE randomised controlled trialKyumin Jang, Rachael L Morton, Brian Burns, et al.
Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.
Contemporary Clinical Trials|August 21, 2017
Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)James E Sharman, Tony Stanton, Christopher M Reid, et al.
Heart (British Cardiac Society)|June 26, 2024
Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysisRajan Rehan, Sohaib Virk, Christopher C Y Wong, et al.
Diabetes Research and Clinical Practice|August 25, 2011
Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD studyDavid Sullivan, Peta Forder, John Simes, et al.
Diabetes Care|September 30, 2003
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trialAnthony Keech, David Colquhoun, James Best, et al.
Journal of Atherosclerosis and Thrombosis|September 13, 2002
Risk factors for coronary heart disease in the Japanese--comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention studyAkira Yamamoto, Gemma Richie, Haruo Nakamura, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2020
Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD StudyEmma S Scott, Andrzej S Januszewski, Rachel O'Connell, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
The Lancet. Diabetes & Endocrinology|December 22, 2019
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participantsNelson Wang, Jordan Fulcher, Nishan Abeysuriya, et al.
Resuscitation|April 12, 2026
Healthcare costs of expedited transport compared with standard care following out-of-hospital cardiac arrest: results from the EVIDENCE randomised controlled trialKyumin Jang, Rachael L Morton, Brian Burns, et al.
Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.
Contemporary Clinical Trials|August 21, 2017
Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)James E Sharman, Tony Stanton, Christopher M Reid, et al.
Heart (British Cardiac Society)|June 26, 2024
Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysisRajan Rehan, Sohaib Virk, Christopher C Y Wong, et al.
Diabetes Research and Clinical Practice|August 25, 2011
Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD studyDavid Sullivan, Peta Forder, John Simes, et al.
Diabetes Care|September 30, 2003
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trialAnthony Keech, David Colquhoun, James Best, et al.
Journal of Atherosclerosis and Thrombosis|September 13, 2002
Risk factors for coronary heart disease in the Japanese--comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention studyAkira Yamamoto, Gemma Richie, Haruo Nakamura, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2020
Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD StudyEmma S Scott, Andrzej S Januszewski, Rachel O'Connell, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Pageof 10